Evaluation of exosomal miR-155, let-7g and let-7i levels as a potential noninvasive biomarker among refractory/relapsed patients, responsive patients and patients receiving R-CHOP

References

• Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–282.
   PubMed Web of Science ®Google Scholar
• Dotan E, Aggarwal C, Smith MR. Impact of rituximab (Rituxan) on the treatment of B-Cell non-Hodgkin’s lymphoma. P T. 2010;35:148–157.
   PubMedGoogle Scholar
• Borgerding A, Hasenkamp J, Glaß B, et al. Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma. Ann Hematol. 2010;89:283–289.
   PubMed Web of Science ®Google Scholar
• Nogai H, Dörken B, Lenz G. Pathogenesis of non-Hodgkin’s lymphoma. J Clin Oncol. 2011;29:1803–1811.
   PubMed Web of Science ®Google Scholar
• Song G, Gu L, Li J, et al. Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients. Ann Hematol. 2014;93:1735–1743.
   PubMed Web of Science ®Google Scholar
• Litwińska Z, Łuczkowska K, Machaliński B. Extracellular vesicles in hematological malignancies. Leuk Lymphoma. 2018;1–8.
   PubMed Web of Science ®Google Scholar
• Calin GA, Ferracin M, Cimmino A, et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005;353:1793–1801.
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–838.
   PubMed Web of Science ®Google Scholar
• Lawrie CH, Saunders NJ, Soneji S, et al. MicroRNA expression in lymphocyte development and malignancy. Leukemia. 2008;22:1440–1446.
   PubMed Web of Science ®Google Scholar
• Kluiver J, Poppema S, de Jong D, et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol. 2005;207:243–249.
   PubMed Web of Science ®Google Scholar
• Eis PS, Tam W, Sun L, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA. 2005;102:3627–3632.
   PubMed Web of Science ®Google Scholar
• Zhong HUA, Xu LAN, Zhong J, et al. Clinical and prognostic significance of miR-155 and miR-146a expression levels in formalin-fixed/paraffin-embedded tissue of patients with diffuse large B-cell lymphoma. Exp Ther Med. 2012;3:763–770.
   PubMed Web of Science ®Google Scholar
• Malumbres R, Sarosiek KA, Cubedo E, et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood. 2009;113:3754–3764.
   PubMed Web of Science ®Google Scholar
• Wu K, Yang Y, Zhao J, et al. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10. Cancer Lett. 2016;371:125–133.
   PubMed Web of Science ®Google Scholar
• Barh D, Malhotra R, Ravi B, et al. MicroRNA let-7: an emerging next-generation cancer therapeutic. Curr Oncol. 2010;17:70–80.
   PubMed Web of Science ®Google Scholar
• Guan J, Guo S, Liu M. Let-7 Family miRNAs Represent Potential Broad-Spectrum Therapeutic Molecules for Human Cancer. J Genet Syndr Gene Ther. 2015. [cited 2018 Jul 12]; 06(03): 1–6. [Internet] Available at https://www.omicsonline.org/open-access/let7-family-mirnas-represent-potential-broadspectrum-therapeutic-molecules-for-human-cancer-2157-7412-1000271.php?aid=62998
   Google Scholar
• Wu L, Wang Q, Yao J, et al. MicroRNA let-7g and let-7i inhibit hepatoma cell growth concurrently via downregulation of the anti-apoptotic protein B-cell lymphoma-extra large. Oncol Lett. 2015;9:213–218.
   PubMed Web of Science ®Google Scholar
• Qian P, Zuo Z, Wu Z, et al. Molecular and cellular pathobiology pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. Cancer Res. 2011;71:6463–6474.
   PubMed Web of Science ®Google Scholar
• Nakajima G, Hayashi K, Xi Y, et al. Non-coding microRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genom Proteom. 2006;3:317–324.
   PubMedGoogle Scholar
• Zhang X, Yuan X, Shi H, et al. Exosomes in cancer: small particle, big player. J Hematol Oncol. 2015;8:83.
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci. 2008;105:10513–10518.
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;79:654–659.
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010;101:2087–2092.
   PubMed Web of Science ®Google Scholar
• Manier S, Liu C-J, Avet-Loiseau H, et al. Prognostic role of circulating exosomal miRNAs in multiple myeloma. Blood. 2017;129:2429–2436.
   PubMed Web of Science ®Google Scholar
• Bairey O, Shacham-Abulafia A, Shpilberg O, et al. Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor. Hematol Oncol [Internet]. 2016 Dec [cited 2018 Oct 27];34(4):184–192.
   PubMed Web of Science ®Google Scholar
• Li J, Hu R, Liao A-J, et al. [Ki-67 proliferative index in non-Hodgkin’s lymphoma and its clinical significance]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011;19:935–939.
   PubMedGoogle Scholar
• Ni H, Tong R, Zou L, et al. MicroRNAs in diffuse large B-cell lymphoma. Oncol Lett. 2016;11:1271–1280.
   PubMed Web of Science ®Google Scholar
• Fang C, Zhu D, Dong H, et al. Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma. Ann Hematol. 2012;91:553–559.
   PubMed Web of Science ®Google Scholar
• Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 2008;141:672–675.
   PubMed Web of Science ®Google Scholar
• Troppan K, Wenzl K, Deutsch A, et al. MicroRNAs in diffuse large B-Cell lymphoma: implications for pathogenesis, diagnosis, prognosis and therapy. Anticancer Res. 2014;34:557–564.
   PubMed Web of Science ®Google Scholar
• Culpin RE, Sieniawski M, Proctor SJ, et al. MicroRNAs are suitable for assessment as biomarkers from formalin-fixed paraffin-embedded tissue, and miR-24 represents an appropriate reference microRNA for diffuse large B-cell lymphoma studies. J Clin Pathol. 2013;66:249–252.
   PubMed Web of Science ®Google Scholar
• Iqbal J, Shen Y, Huang X, et al. Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. Blood. 2015;125:1137–1145.
   PubMed Web of Science ®Google Scholar
• Caramuta S, Lee L, Ozata DM, et al. Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma. Blood Cancer J. 2013;3:e152.
   PubMed Web of Science ®Google Scholar
• Roehle A, Hoefig KP, Repsilber D, et al. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br J Haematol. 2008;142:732–744.
   PubMed Web of Science ®Google Scholar
• Falcone G, Felsani A, Agnano ID, et al. Signaling by exosomal microRNAs in cancer. J Exp Clin Cancer Res. 2015;34:32.
   PubMed Web of Science ®Google Scholar
• Jung I, Aguiar RCT. MicroRNA-155 expression and outcome in diffuse large B-cell lymphoma. Br J Haematol. 2009;144:138–140.
   PubMed Web of Science ®Google Scholar
• Alencar AJ, Malumbres R, Kozloski GA, et al. MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Clin Cancer Res. 2011;17:4125–4135.
   PubMed Web of Science ®Google Scholar
• van Eijndhoven MAJ, Zijlstra JM, Groenewegen NJ, et al. Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients. JCI Insight. 2016;1:e89631.
   Google Scholar
• Lu X, Nechushtan H, Ding F, et al. Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas. Blood. 2005;105:2924–2932.
   PubMed Web of Science ®Google Scholar
• Gallo A, Tandon M, Alevizos I, et al. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One. 2012;7:e30679.
   PubMed Web of Science ®Google Scholar